Van Laar, R. K. (2012). Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung cancer. BioMed Central.
Dyfyniad Arddull ChicagoVan Laar, Ryan K. Genomic Signatures for Predicting Survival and Adjuvant Chemotherapy Benefit in Patients With Non-small-cell Lung Cancer. BioMed Central, 2012.
Dyfyniad MLAVan Laar, Ryan K. Genomic Signatures for Predicting Survival and Adjuvant Chemotherapy Benefit in Patients With Non-small-cell Lung Cancer. BioMed Central, 2012.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.